- Report
- February 2024
- 75 Pages
North America
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- December 2023
- 193 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- January 2023
- 52 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- October 2018
- 50 Pages
Global
From €3323EUR$3,495USD£2,791GBP
- Report
- November 2023
- 109 Pages
Africa, Middle East
From €2804EUR$2,950USD£2,356GBP
- Report
- November 2023
- 119 Pages
North America
From €2804EUR$2,950USD£2,356GBP
- Report
- November 2023
- 190 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- September 2022
- 160 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- September 2022
- 342 Pages
Global
From €9031EUR$9,500USD£7,587GBP
- Book
- October 2021
- 400 Pages
- Report
- March 2022
- 98 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- January 2024
- 104 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- April 2024
- 74 Pages
United States
From €1041EUR$1,095USD£875GBP

The Obesity market is a therapeutic area that focuses on the treatment of obesity and related conditions. It includes a range of treatments, from lifestyle changes such as diet and exercise to medications and surgical interventions. The goal of these treatments is to reduce the risk of obesity-related health complications, such as type 2 diabetes, heart disease, and stroke.
The market is driven by a growing awareness of the health risks associated with obesity, as well as the increasing prevalence of the condition. Additionally, advances in medical technology have enabled more effective treatments for obesity, such as bariatric surgery.
Several companies are active in the Obesity market, including Novo Nordisk, Orexigen Therapeutics, Arena Pharmaceuticals, and Vivus. These companies are focused on developing treatments for obesity, ranging from lifestyle interventions to medications and surgical interventions. Show Less Read more